40 results on '"Chen, Liqun"'
Search Results
2. Supplemental Figure 1 from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
3. Data from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
4. Supplementary Data for publication from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
5. Supplemental Figure 2 from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
6. Supplemental Figure 2 from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
7. Supplementary Data for publication from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
8. Data from A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
9. Data from BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway
10. Data from BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway
11. Supplementary methods and Supplementary Figures S1-S8 from BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway
12. Supplementary Figures 1-5 from Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3
13. Supplementary Figures 1-5 from Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3
14. Supplementary Figures S1-S6 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
15. Supplementary Table S1 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
16. Data from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
17. Data from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
18. Supplementary Table S2 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
19. Supplementary Table S3 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
20. Supplementary Table 1, Figures 1-4, Methods from Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells
21. Supplementary Methods from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
22. Supplementary Figure Legend from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
23. Supplementary Methods from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
24. Supplementary Table 1, Figures 1-4, Methods from Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells
25. Data from Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells
26. Supplementary Table S3 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
27. Supplementary Table S2 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
28. Supplementary Table S1 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
29. Supplementary Figures S1-S6 from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
30. Supplementary Figure Legend from Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
31. Abstract 5331: Targeted protein degradation for the treatment of TRK fusion-driven cancers
32. BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway
33. A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
34. Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB
35. Abstract 3578: Androgen receptor transcriptionally targets the ErbB3 regulator Nrdp1 in the presence of nuclear Filamin A.
36. Abstract 1323: Identification of conditions of lapatinib effectiveness in prostate cancer.
37. Abstract A12: Identification of Nrdp1 as a novel androgen receptor transcription target differentially regulated in androgen-dependent and independent prostate cancer
38. Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3
39. Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells
40. Abstract A75: Dual inhibition of EGFR and ErbB2 during androgen ablation prevent the progression of prostate cancer cells to androgen independence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.